Tuesday, February 22, 2011 10:29:22 AM
Looks like the 200 Day Moving Average is now down to 0.0156. Should be easier to get break through with the right news, which in my book, is high profile marketing alliances and partners that confirms that MedFlash is being accepted out there.
Of course, a contract with some projected (conservative) revenues for the year would really confirm things. Still, it is the low public float that keeps me here for the trading. Trying to build a position that I basically own free and clear.
Of course, a contract with some projected (conservative) revenues for the year would really confirm things. Still, it is the low public float that keeps me here for the trading. Trying to build a position that I basically own free and clear.
Recent CUBT News
- Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement • GlobeNewswire Inc. • 05/07/2026 11:00:00 AM
- Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic Therapy • GlobeNewswire Inc. • 04/15/2026 12:08:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:05:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:00:00 AM
- Curative Biotechnology Announces Canadian Patent Allowance • GlobeNewswire Inc. • 01/23/2026 01:45:00 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 12/22/2025 06:40:01 PM
- Curative Biotechnology, Inc. Announces Letter to Shareholders • GlobeNewswire Inc. • 11/18/2025 01:15:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/01/2025 08:07:47 PM
